Dupree Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$717K Hold
620
– – 0.26% 51
2026
Q2
$744K Hold
620
– – 0.28% 53
2026
Q1
$570K Buy
620
+25
+4% +$25.3K 0.23% 53
2025
Q4
$639K Sell
595
-15
-2% -$14.3K 0.23% 51
2025
Q3
$465K Hold
610
– – 0.18% 49
2025
Q2
$476K Buy
610
+29
+5% +$22.5K 0.19% 52
2025
Q1
$480K Sell
581
-2
-0.3% -$1.66K 0.19% 51
2024
Q4
$450K Buy
583
+32
+6% +$26.5K 0.21% 48
2024
Q3
$488K Hold
551
– – 0.2% 51
2024
Q2
$499K Hold
551
– – 0.23% 43
2024
Q1
$429K Hold
551
– – 0.19% 41
2023
Q4
$321K Buy
+551
New +$322K 0.16% 44

Other funds holding LLY

Dupree Financial Group's LLY Position: Q3 2026 in Review

Dupree Financial Group held its Eli Lilly (LLY) position steady in Q3 2026 at 620 shares worth $717K. The position accounts for 0.26% of the portfolio, ranked #51.

Dupree Financial Group first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $744K in Q2 2026. 272 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Dupree Financial Group held 620 shares of Eli Lilly worth $717K as of Q3 2026.
  • Dupree Financial Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.26% of Dupree Financial Group's portfolio in Q3 2026, its #51 holding.
  • Dupree Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Dupree Financial Group's Eli Lilly position peaked at $744K in Q2 2026.
  • 272 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Dupree Financial Group's 13F filing for Q3 2026, filed 9 Oct 2026.